HemOnc Today

The content you need, when you need it.

[HemOnc Today @HemOncToday]

📱 A mobile health tool significantly addressed survivorship concerns & informational needs for early-onset #BreastCancer

Dr. @ShoshRosenberg @WeillCornell discussed the data with @GoHealio.
See what's changing the outlook of early-onset breast cancer ⬇️ https://t.co/cHCWsqsLmW

[HemOnc Today @HemOncToday]

A 4️⃣-drug regimen may help some patients with metastatic #BreastCancer avoid #chemotherapy in the first-line setting, per @JNCI_Now data.

A larger randomized trial is needed to compare the combination to standard therapies.
https://t.co/GDfi7v0IpE

[HemOnc Today @HemOncToday]

💊 Can #GLP-1 agents prevent #cancer?

The signal from retrospective data is “probably as strong as it will ever be” but “now is the time” to validate findings prospectively, @theglpman @UTHealthSA says.

Read the latest in this #HealioExclusive 👇 https://t.co/v4VTIoeXKB

[HemOnc Today @HemOncToday]

🚨 Most #ProstateCancer clinical trials occur in high-income countries. Only six of 77 low-middle or low-income countries had any clinical trial.

🗨️ “It really paints a picture of how wide these disparities are,” @vabreugoes @cityofhope https://t.co/rN5xAs6ynT

[Women in Oncology @WomeninOnc]

📆 Today is National Women in Medicine Day! Join Healio’s Women in Oncology in recognizing the efforts and contributions of women across all #healthcare professions.

Read the top stories from contributions from female oncologists 👇 https://t.co/xXW3WEdX8G

[Healio Dermatology @HealioDerm]

🏖️Sunscreen is not just for summer🏖️

📚✏️As students head back to school, we talk all things sun safety with @GoHealio Dermatology Peer Perspective Board Member Dawn Marie R. Davis, MD, of @MayoClinic.

Read the Q&A ⬇️
@IDinChildren @HemOncToday
https://t.co/X8WW2qaVhw

[HemOnc Today @HemOncToday]

📝 A survey of @NCCN member institutions reveals several #cancer drugs in shortage.

The agents most often in short supply:

❌ Ifosfamide (94%)
❌ Carboplatin (71%)
❌ Bacillus Calmette Guérin (51.6%)
https://t.co/ciuhPy5idO

[HemOnc Today @HemOncToday]

❗ @JournalCancer data document “shocking” gaps in #screening for #BreastCancer, #CervicalCancer & #ColorectalCancer among adults with disabilities.

The largest disparities exist for those with self-care disabilities, such as difficulty dressing.
https://t.co/DG3y1zpL6m

[HemOnc Today @HemOncToday]

🎉 #NationalWomenInMedicineDay: Celebrating women shaping medicine 🩺

🤰Progress has been made for physicians planning to start a family, but obstacles persist.

@GoHealio spoke with medical professionals at @MGHSurgery, @UTMDAnderson & UnityHealthTO 👇 https://t.co/H3UFcUBm0d

[HemOnc Today @HemOncToday]

🩸 🧪 Researchers at @cityofhope developed a blood test that may detect #PancreaticCancer earlier.

📖 #PANXEON also detected high-grade dysplasia, per @NatureMedicine data. This could enhance monitoring or allow for intervention prior to invasive disease. https://t.co/BF4SPqi9Yc

[HemOnc Today @HemOncToday]

💤 #Sleep is ‘critically important’ for #cancer survivors’ health.

Too little or too much may ⬆️ risk for frequent mental & physical distress, per @timpawlik @OhioStateSurg @OSUWexMed & colleagues. https://t.co/xqTBMbjvMY

[HemOnc Today @HemOncToday]

New data in @JAMANetworkOpen reveal “worrisome” trends in #CervicalCancer screening in the U.S.

Nearly 3️⃣2️⃣% of women aged 21 to 29 have never been screened.

About 1️⃣5️⃣% of those aged 30 to 64 have never been screened. https://t.co/gs4YtPxwSV

[HemOnc Today @HemOncToday]

JUST RELEASED: The 2026 @AACR #CancerProgressReport provides key updates on the #cancer treatment landscape and what is on the horizon.

✨ It instills an “overwhelming sense of positivity,” Dr. Catherine Bollard @ChildrensNatl says. https://t.co/iJwEWHEUXZ

[HemOnc Today @HemOncToday]

Presentation health can help explain survival disparities in pediatric #AML between Black and white children.

🗨️ “If we want to eliminate these disparities, we have to look beyond the cancer itself,” Dr. Daniel J. Zheng @ChildrensPhila told Healio. https://t.co/Hp1jLFWm11

[HemOnc Today @HemOncToday]

❗ #MetabolicHealth should be frequently evaluated in men with #ProstateCancer receiving hormone therapy and ARPIs.

📖 Data from @JAMAOnc show this patient population has high rates of #MetabolicSyndrome development.

#ProstateCancerAwarenessMonth https://t.co/nJ16gl8tlW

[HemOnc Today @HemOncToday]

#Transplantation & #CellularTherapy may have a profound impact on #AutoimmuneDisease & other immunological disorders.

Dr. David Porter @PennMedicine & Dr. Claudio Brunstein @ClevelandClinic explain what the multidisciplinary meeting on the topic offers 👇 https://t.co/N5RRoHtIgS

[HemOnc Today @HemOncToday]

🏥 More than one-quarter of #Medicare beneficiaries with #cancer received their diagnosis after an ED visit.

Poor survival in this group highlights the need for appropriate referral pathways, says Dr. Caroline Thompson @UNCpublichealth @UNC_Lineberger. https://t.co/KM2dylnbz8

[HemOnc Today @HemOncToday]

Trusted vaccine guidance shouldn’t be buried in a search.

Healio AI helps you quickly surface evidence-based answers from respected clinical resources, including The Vaccine Handbook (The Purple Book).

Try it now with a sample prompt: https://t.co/lwQtrFQ4Ae
#HealioAI #Vaccines

[HemOnc Today @HemOncToday]

🤗 Problem-solving coping strategies & social support can aid the transition to adult #healthcare for adolescents with #SickleCellDisease.

Dr. Apoorva S. Iyengar @LurieChildrens spoke with @GoHealio about supporting patients at this “overwhelming” period. https://t.co/nb2jb0OCNO

[HemOnc Today @HemOncToday]

💙 Celebrating Nursing Professional Development Week and the nurses who never stop learning, growing and making a difference in patient care.

Take a well-deserved brain break with WORD DOC.

Play now: https://t.co/lLbahScCud

#NursingProfessionalDevelopmentWeek #Nurses #WORDDOC

[Healio Gastroenterology @HealioGastro]

🗨️An investigational blood test may address the “Achilles’ heel” of blood-based #ColorectalCancer screening: detection of precancerous lesions, Dr. Ajay Goel @CityofHope told @GoHealio.

🩸 The assay, dubbed DENEB, had 81% sensitivity for #AdvancedAdenomas
https://t.co/JBX0r4OC0H